AI discovery platforms replacing analytical scientists
#1Integrated platforms like AlphaFold (3+ million structure predictions), Recursion Pharmaceuticals (automated phenotypic screening + AI analysis), and Insilico Medicine (AI-designed drug INS018_055 in Phase II trials) are consolidating discovery pipelines. These platforms handle target identification, hit finding, and lead optimization with minimal human analytical input. DeepMind's AlphaFold has effectively automated a task (protein structure prediction) that sustained thousands of structural biology careers.